|Articles|May 3, 2004

Should hydrocodone meds shift to Schedule II?

DEA is considering switching hydrocodone to Schedule II, prompting opposition from pharmacists

Newsletter

Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.

Subscribe Now!

Related Content

woman awake holding glass near alarm clock

FDA Approves New Insomnia Therapy: What Pharmacists Need to Know

ByKaren Berger, PharmD

January 21st 2022

Acetaminophen Reduces Opioid Treatment Duration, Study Shows

ByMiranda Hester

January 6th 2022

health care finances on screen and selection options

Price Competition As Result of New Drug Approval

ByPeter Wehrwein

January 3rd 2022

Targeted Drug Combination Reveals New Activity in Brain Tumors

December 28th 2021

FDA Issues EUA for First Oral Antiviral Pill for COVID-19

ByFrank Diamond

December 22nd 2021

Should hydrocodone meds shift to Schedule II?

Newsletter

Related Content

FDA Approves New Insomnia Therapy: What Pharmacists Need to Know

Acetaminophen Reduces Opioid Treatment Duration, Study Shows

Price Competition As Result of New Drug Approval

Targeted Drug Combination Reveals New Activity in Brain Tumors

FDA Issues EUA for First Oral Antiviral Pill for COVID-19

Trending on Drug Topics

Immunization: Most-Read Stories of 2025

Top 5 Over The Counter Episodes From 2025

Q&A: Growth in Social Media Use Blurs the Lines of How Pharmacists Should Post

Protecting Patient Privacy Safeguards Pharmacists’ Professional Reputation

Obesity Management: Most-Read Stories of 2025